Major Private Insurer Raises 2026 Earnings Outlook to Over $18.25 Per Share

UnitedHealth Group reported first-quarter 2026 earnings on April 21, 2026, that exceeded Wall Street expectations for both revenue and earnings per share. The company simultaneously raised its full-year profit outlook, citing improved management of medical costs and the streamlining of its operations.

The company now expects 2026 adjusted earnings to be greater than $18.25 per share, an increase from its previous forecast of more than $17.75 per share. According to data compiled by LSEG, analysts had previously expected a profit of $17.86 per share for the year.

First-Quarter Financial Performance

For the first quarter of 2026, UnitedHealth reported adjusted earnings per share of $7.23, surpassing the $6.57 consensus estimate. Consolidated revenue for the period reached $111.72 billion, compared to the $109.57 billion expected by analysts.

Net income for the quarter was $6.28 billion, or $6.90 per share. This figure was nearly unchanged from the first quarter of the previous year, when the company reported net income of $6.29 billion, or $6.85 per share. Earnings from operations were $9.0 billion, while cash flows from operations totaled $8.9 billion.

UnitedHealth is maintaining its full-year revenue guidance of more than $439 billion. The company stated in January 2026 that this guidance reflects right-sizing across the enterprise.

Medical Costs and Profitability Metrics

A key indicator of the insurer’s profitability, the medical benefit ratio, was 83.9% for the first quarter. This ratio, which measures total medical expenses paid relative to premiums collected, was lower than the 85.5% analysts had anticipated and an improvement over the 84.8% recorded in the same period the previous year.

The improvement in the ratio was attributed to disciplined cost controls and the unwinding of reserves previously held against money-losing contracts within the Optum health services unit. However, UnitedHealth cautioned that medical costs remained consistently elevated.

The Optum unit acted as a drag on overall results, with quarterly revenue decreasing slightly due to a drop in coordinated care plan enrollment.

Strategic Turnaround Plan

The financial results follow the implementation of a turnaround plan led by CEO Stephen Hemsley, who assumed the role nearly a year prior to the April 21, 2026, report. The strategy is designed to rebuild investor confidence following a period marked by a federal probe, escalating medical costs, and the death of a senior executive.

The company’s current strategy includes several operational shifts:

• Selling the United Kingdom business of the Optum health-care unit.
• Exiting certain health plans and non-U.S. Businesses.
• Increasing investments in artificial intelligence.
• Shrinking membership to restore profitability.
• Streamlining access to care and increasing transparency.

CFO Wayne DeVeydt stated that the company is maintaining a prudent approach to its 2026 outlook to ensure trust and transparency. DeVeydt noted that while the company beat quarterly estimates, leadership wants to monitor trends in April and May before raising guidance further.

Market Reaction

Following the announcement, UnitedHealth shares rose between 7% and 9.62% in premarket trading. The positive results also impacted industry peers, with Humana and CVS Health seeing share increases between 3% and 5%.

Morningstar analyst Julie Utterback noted that investors likely recognize that margins may have reached their lowest point in 2025, and the upward movement of 2026 guidance represents a positive shift compared to the previous year.

Despite the upbeat profit forecast, Yahoo Finance reported that UnitedHealth stock later faced pressure as a Medicare blow offset some of the gains from the earnings report.